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Introduction
With 60% of currently marketed drugs targeting membrane proteins 1 , it is clear that finding small molecules to modulate the function of such proteins is essential. High throughput screening (HTS) methods have been successful in identifying such compounds, but because the methods of detection rely on functional assays, they are generally only sensitive to submicromolar interactions. Such relatively tight interactions are generally only observed for larger compounds (300-500 Da). However, it has proved challenging to simultaneously optimize potency and absorption, distribution, metabolism, and excretion (ADME) properties of these "lead-like" or "drug-like" compounds.
Furthermore, such large compounds inefficiently explore the binding sites of of so-called drug "fragments" that are often described by a "rule of threes" 3 (Ro3, M r < 300 Da, cLogP < 3, H-bond donors < 3, H-bond acceptors < 3, number of rotatable bonds < 3 and TPSA (total polar surface area) < 60 Å 2 ) for binding to the target. Ro3 compliant compounds typically bind the target with K D greater than 10 µM. In order to detect such weak binding, sensitive biophysical techniques are typically required, particularly when the target s not an enzyme.
Commonly used techniques for detecting fragment binding include NMR, X-ray crystallography and surface plasmon resonance (SPR) 4 .
Although biophysical methods have been successfully applied to an array of soluble protein targets 5 , they have failed in one way or another when applied to membrane proteins. There are two primary reasons for this failure: insufficient quantity of the target and problems related to the solubilization media. Many biophysical methods require tens or even hundreds of mg of purified, functional protein and most membrane proteins are difficult to produce in these quantities.
However, recent advances have enabled the production of low mg quantities of a variety of MPs [6] [7] [8] . Membrane proteins that can be produced in sufficient quantity must then be solubilized in a surfactant while maintaining their functional state, which is also often challenging. Finally, non-specific partitioning of fragments into the surfactant has been a severe problem leading to high levels of false positives.
The use of detergent micelles to solubilise MPs has only met limited success in retaining the native function of the protein while at the same time the micelles often interfere with biophysical assays. A possible solution to this bottleneck would be to employ non-detergent media to functionally solubilize
MPs. The Nanodisc (ND) has been developed as an alternative, surfactant free approach to solubilize MPs. NDs consist of a lipid bilayer that is surrounded by an amphiphilic α-helical membrane scaffold protein (MSP). A variety of proteins have been functionally solubilized in NDs [9] [10] [11] , which are much better mimics of the native membrane than detergent micelles. However, the suitability of NDs for biophysical assays of ligand binding to MPs has yet to be determined.
An NMR-based fragment screening approach has been developed and has proven capable of overcoming many of the challenges posed by membrane proteins 12 . The approach, called Target Immobilized NMR Screening (TINS) 13 , involves immobilizing a target and a reference in two compartments of a dual-cell sample holder 14 and simultaneously injecting mixtures of fragments in an automated process. For each mixture a 1D 1 H NMR spectrum is recorded while fragment binding to the target protein results in a decrease in peak amplitude.
The reference, which is selected for minimal specific small molecule binding, serves to cancel out non-specific binding of fragments to protein surfaces. Hits can therefore be detected by comparing spectra of the compounds recorded in the presence of the target to those recorded in the presence of the reference. By repeatedly using the same sample to screen the entire fragment collection (>1,000 compounds), typically only ~25 nmol of protein is required, thus bringing many MPs within the requirements for TINS. Furthermore, the reference system is expected to account for non-specific binding of fragments to the media in which the membrane protein is solubilized.
It was sought to apply TINS to a bona fide, integral membrane pharmaceutical target that could be functionally solubilized in detergent micelles 
Results

DsbB Functional Immobilization and Enzymatic Activity
Wildtype DsbB (containing endogenous quinone) has previously been solubilized in DPC micelles, which we refer to as DsbB/DPC, with retention of enzymatic function 23 To monitor the integrity of the DsbB sample during the screen, the binding of 
Comparison of Micelle Solubilized vs ND Solubilized Protein for Ligand
Binding Studies
The influence of detergent or ND on the quality of the NMR spectra of the fragments is shown in Figure 2 (d and e). In both cases the compound whose spectrum is shown in 3c can be identified as specifically binding to DsbB. The stability of the empty ND (-/ND) as shown in Figure 1b , affords the possibility to use NDs directly as a generic reference to account for non-specific ligand binding to the phospholipid bilayer and the scaffolding protein. To investigate this, we screened all 183 compounds for binding to DsbB/ND using either OmpA/ND or -/ND as a reference. By plotting the T/R for each compound from the screen using -/ND versus that using OmpA/ND we derive a twodimensional plot that gives an overview of the performance of the screen ( Figure   3a ). Overall there was a reasonable correlation in ligand binding to DsbB/ND using either empty NDs or OmpA/ND as the reference (R 2 =0.78). In general however, the T/R ratio of fragments is lower with -/ND as a reference, indicating that specific binding to DsbB/ND is more pronounced. Since the NMR spectra of the fragments in the presence of DsbB/ND in the screen vs -/ND or OmpA/ND are similar, this suggests a higher level of non-specific binding of the fragments to OmpA/ND. We conclude therefore that -/ND is the preferred reference. We then compared the ligand screening results from DsbB/DPC (OmpA/DPC as reference) to those from DsbB/ND (-/ND as reference). Upon inspection of the raw NMR data from the DPC screen we observed that although 183 compounds were present in the 40 mixes selected, only 127, about 2/3, gave observable NMR spectra. Presumably, those compounds missing from the NMR data had non-specifically adsorbed to the micelle. In contrast, 164 of 183 compounds gave observable spectra in the ND screen. Of the 127 compounds with observable spectra in the DPC screen, 70 were of sufficiently high quality to allow a reliable comparison with the ND screen and we therefore focused our efforts on these. Inspection of Figure 3b clearly shows that the correlation between the micelles and NDs is much less pronounced than between the two ND references. Using the same criteria for hit selection for both, 22 hits were identified for DsbB/ND and 22 were identified for DsbB/DPC. Of these biophysically detected hits, 14 were common to both the micelle and ND (red) screen while 7 were unique to the ND screen (blue) and 8 unique to the micelle screen (green, see also Table 2 ). We analyzed the solubility of each of the fragment hits using the calculated Log of the octonal/water partition coefficient (cLogP). Interestingly, the hits specific for the ND screen are on average slightly less soluble in water than the hits found in both screens, but the hits specific to the micelle screen are considerably more soluble (Table 2) . A possible explanation for this observation is that the less soluble fragments exhibited greater non-specific binding to the micelle, thus masking specific binding to DsbB. This observation is consistent with the NMR data in Figure 2 .
Hit Validation using Enzymatic Assays
The TINS assay simply identifies compounds that bind to DsbB, but not necessarily in a biologically relevant manner. Therefore we felt it was critical to validate the hits in terms of biological activity. An enzymatic assay was used to assess the ability of the compounds to inhibit electron transfer mediated by DsbB. Each of the 93 fragments identified as TINS hits in the micelle screen was assayed for inhibition of DsbB-dependent reoxidation of DsbA at 250 µM, as shown in appendix. The bioassay was also used to compare hits selected in the micelle screen to those selected in the ND screen (see Table 2 ). As expected, fragments common to both the micelle and ND screens yielded a strong correlation with biological activity with 12/14 exhibiting medium (30-70%) or high (>70%) inhibition of DsbB in both micelles and NDs. We observed a good correlation between ligands detected in the ND screen and biochemical activity against both micelle and ND solubilized DsbB where 6/7 compounds had medium inhibitory activity and the seventh was a mild stimulator. In contrast, while the micelle specific ligands correlated reasonably well with the bioassay using detergent solubilized DsbB where 5/8 were medium or strong inhibitors, none inhibited DsbB/ND.
Discussion
The use of Ro3 compliant, "drug fragments" as a starting point for drug discovery has delivered a number of innovative compounds against soluble targets which are currently in clinical trials 26 . Membrane proteins have not made good targets for FBDD due to their challenging physicochemical properties. In particular, the difficulty of generating sufficient quantities of purified, functional protein and of detecting specific binding to the target, as opposed to non-specific partitioning into hydrophobic phases, have limited the applicability of biophysical ligand screening approaches. Here we have addressed these two issues by a)
immobilizing the target and reusing a single sample to screen an entire fragment collection and b) using a reference sample to cancel out non-specific interaction of the fragments with the hydrophobic phase. Using TINS we have screened a collection of nearly 1,100 fragments with a single sample of less than 2 mg of protein and demonstrated that the protein was stable throughout the procedure.
The stability of DsbB to repeated cycles of fragment application and washing depends on detergent micelles and the quinone cofactor. The detergent requirement could be overcome by including it in the buffer or using NDs to solubilize the protein. Endogenous UQ-8 binds DsbB very tightly and is quite resistant to repeated detergent washing 27 .
Screening of the fragment library resulted in 93 ligands that were specific for DsbB. A number of observations suggest that most of these ligands are directly binding to DsbB and not indirectly via the micelle (see appendix). First, the DsbB binding detected using TINS was relative to OmpA solubilized in identical conditions. Second, there is a range of potencies in the enzyme inhibition studies that includes a small number of non-inhibitors and activators.
Third, and perhaps more critically, inhibition is saturable and occurs over 2 log orders, strongly suggesting a stoichiometric interaction. suggesting a reduced tendency of hydrophobic compounds to partition into the nanodisc.
As described in appendix, the eight fragments with greatest potency in the single concentration enzyme inhibition assay were fully characterized for potency, mode of action, and binding site on DsbB. A simplistic analysis suggests that these fragments can be divided into two groups, one that competes only with quinone for DsbB binding and a second that perturbs the apparent affinity of represents a high quality reference system to remove false positives. This conclusion is strongly supported by the observation that the 8 DsbB/DPC specific hits failed to inhibit DsbB/ND while 7 of 8 DsbB/ND hits also inhibited DsbB/DPC.
Apparently, despite the reference sample, some compounds interact with DsbB in a micelle specific manner. This problem would be eliminated by using NDs.
Significance
Integral membrane proteins make up a significant portion of the human Our results clearly establish the feasibility of using a fragment-based approach for finding starting matter for subsequent development of compounds targeting membrane proteins, including the all-important GPCR class of proteins.
In addition, increasing success in the preparation of membrane proteins in reasonable quantities should make many such proteins amenable to the use of TINS for fragment screening, thereby increasing its general utility.
Methods
Protein Purification
DsbA, DsbB, and OmpA were expressed and purified as previously reported [28] [29] [30] . All proteins have a 6x-His tag at the N-terminus or C-terminus for affinity purification.
ND Self-Assembly
The ND self assembly procedure was repeated the same way for both
OmpA and DsbB with slight adaptations from the previously reported 
Appendix Target Immobilized NMR Screening (TINS) of DsbB/DPC
The fragment collection was screened for binding to DsbB at 500 µM each, in 182 mixtures. A spatially selective Hadamard NMR experiment 1 was used to simultaneously acquire a 1D 1 H spectrum of compounds in the presence of DsbB/DPC or OmpA/DPC. The data resulting from the screen could be analysed directly without deconvolution because fragments could be directly identified by comparing peaks from TINS spectra with reference spectra of the individual fragment. The screen resulted in 93 hits for DsbB, defined as fragments which had a T/R ratio less than 0.3. This particular cut-off was chosen by virtue of a step-like relationship between the observed TINS effect and the number of "hits" whereby even slightly raising the cut-off gave a large increase (> 2-fold) in the number of compounds that were selected as hits (not shown). The resulting hit rate for DsbB was 8.7% which is well within the range we typically observe with soluble proteins using TINS (3-9.5%). Application of the same criteria to OmpA/DPC binding identified seven compounds as hits for a hit rate of 0.6%, validating the earlier data suggesting that OmpA/DPC has minimal small molecule binding capacity.
Hit Validation using Enzymatic Assays
All fragments from the screen that were designated as positive for binding were assayed for DsbB inhibition at 250 µM. The amount of DMSO in all biochemical assay controls was adjusted to match the amount present when fragments were tested. Those compounds that showed more than 70% inhibition at 250 µM were further characterized by titration from 0.0001 mM to 10 mM to generate IC 50 curves. The mode of action for the 8 most potent fragments was determined from competition enzyme assays. (Table A1) and consisted of a variety of scaffolds ( Figure A1 ). The calculated binding efficiency index 2 (Table A1) indicates that these fragments are all very good or excellent starting points for hit elaboration projects. Table A1 .
As a second validation step, we carried out a more detailed kinetic analysis of the mode of action of the 8 most potent fragments. Substrate-velocity experiments were performed in which either DsbA or UQ1 were titrated in the presence of saturating amounts of the other. The titrations were then repeated in the presence of increasing amounts of the inhibitory fragment ( Figure A2 , Table A2 ). In this analysis, fragments 1-3 behaved similarly. This group is exemplified by fragment 2 where increasing concentrations result in moderate perturbation of the maximum enzymatic turn over rate (k cat ) and apparent affinity of DsbA but a dramatic reduction (> 6-fold) in the apparent affinity of UQ1. This result suggests that fragments 1-3 compete for the same binding site as UQ1. On the other hand, addition of fragments 4-8 simultaneously decreased both the apparent affinity and the k cat for UQ1 and DsbA as best exemplified by fragment 8 ( Figure A2 ). This data suggests a mixed model of inhibition of DsbB by these fragments. We next sought biophysical confirmation of these two different modes of fragment interaction with DsbB. Table 2 in the absence and presence of the indicated amount of each inhibitor. Figure A3 , the sidechain indole of The fast exchange is likely due to competition between 2 and the quinone moiety of the bound UQ8, consistent with the competitive kinetics observed for this inhibitor. However, we have shown that the isoprenyl tail of UQ8 extends down the groove between TM1
and TM4, making extensive interactions with the protein 3 . Therefore, displacement of the 
